The May 29, 2026 PDUFA targets pediatric approval of Afrezza for type 1 or type 2 diabetes, leveraging INHALE-1 outcomes versus rapid-acting analogs plus basal insulin. INHALE-1 was open-label and ...
Zahra Mahmoudjafari explains how cell and gene therapy programs succeed with strong infrastructure, pharmacy leadership, ...
A custom NGS panel covering 27 IARC carcinogenic HPV genotypes enabled detection of ccfHPV DNA across treatment strata and ...
The results show that those with low vitamin D levels had a significantly higher risk of hospitalization related to respiratory tract infection compared with those whose 25 (OH)D levels were 75 nmol/L ...
A secondary analysis of the phase 3 KEYNOTE-716 trial finds that adjuvant Keytruda improves recurrence-free survival without increasing the risk of new primary melanoma and may reduce non-melanoma ...
Cost-effectiveness is highly price-sensitive; lower U.S. prices, particularly approaching European levels, shift semaglutide toward favorable value rather than a binary go/no-go determination. Patient ...
“GLP‑1s have effectively created a third pillar of pharmacy spend and most employers don't yet have a mature playbook to manage it,” Conway said, adding that over half of employers now cite GLP‑1s as ...
Hospitals and cancer centers that are launching cell and gene therapy programs need more than scientific breakthroughs to succeed. Delivering these therapies safely and efficientl ...
Provisions in the One Big Beautiful Bill Act (OBBBA) are projected to reduce total Medicaid funding flowing through state programs by $664 billion between 2025 and 2034, according to an analysis of 12 ...
In the first segment of a video interview with MHE, the CEO of Risant Health discusses the role of scale in following ...
Researchers highlighted the anti-inflammatory benefits of GLP-1 receptor agonists in people with HIV, plus a growing concern over rising STI rates and the cautious promise of doxycycline post-exposure ...
Jaewon Ryu is the CEO of Risant Health, which comprises Geisinger Health in north central Pennsylvania and Cone Health in ...